Investigators proposed an antifibrotic strategy that combined prosenescence with enhanced immune clearance through targeted delivery of manganese via albumin-mediated transcytosis, specifically aimed at inducing senescence and eliminating activated HSCs in liver fibrosis.
[Nano Letters]